Chandra R. Tate

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

Chandra R. Tate, Lyndsay V. Rhodes, H. Chris Segar et al. · Breast Cancer Research · 2012 · 263 citations · Full text

Medicine, Oncology, Pharmacology +15

Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice

Jun‐Ho Kim, Matthew S. Meyers, Saja S. Khuder et al. · Molecular Metabolism · 2014 · 112 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators

Lyndsay V. Rhodes, Chandra R. Tate, H. Chris Segar et al. · Breast Cancer Research and Treatment · 2014 · 102 citations · Full text

Medicine, Cancer Biology, Oncology +16

Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis

Joseph P. Tiano, Chandra R. Tate, Bin Yang et al. · Scientific Reports · 2015 · 49 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Effects of SDF-1–CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells

Lyndsay V. Rhodes, Melyssa R. Bratton, Yun Zhu et al. · Experimental Cell Research · 2011 · 36 citations · Full text

Life Sciences, Molecular Biology, Oncology +16